Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 22;12(19):6130.
doi: 10.3390/jcm12196130.

The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review

Affiliations
Review

The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review

Gaby Moawad et al. J Clin Med. .

Abstract

Uterine Adenomyosis is a benign condition characterized by the presence of endometrium-like epithelial and stromal tissue in the myometrium. Several medical treatments have been proposed, but still, no guidelines directing the management of adenomyosis are available. While a hysterectomy is typically regarded as the definitive treatment for adenomyosis, the scarcity of high-quality data leaves patients desiring fertility with limited conservative options. Based on the available data, the levonorgestrel-IUD appears to offer the most favorable outcomes. Other treatments, including GnRH antagonists, dienogest, prolactin, and oxytocin modulators, show promise; however, further data are required to establish their efficacy definitively. Furthermore, there are many emerging therapies that have been developed that seem worthy of consideration in the near future. The aim of this narrative review was to explore the current medical treatments available for adenomyosis and to provide a glimpse of future therapies under assessment. For this scope, we performed a literature search on PubMed and Medline from incept to September 2022 using the keywords: "medical treatment", "non-steroidal anti-inflammatory", "progesterone intrauterine device", "dienogest", "combined oral contraceptives", "gonadotropin releasing hormone agonist", "gonadotropin releasing hormone antagonist", "danazol", "aromatase inhibitors", "ulipristal acetate", "anti-platelet therapy", "dopamine", "oxytocin antagonists", "STAT3", "KRAS", "MAPK", "micro-RNA", "mifepristone", "valproic acid", "levo-tetrahydropalamatine", and "andrographolide". The search was limited to articles in English, with subsequent screening of abstracts. Abstracts were screened to select relevant studies.

Keywords: adenomyosis; gonadotropin releasing hormones; intrauterine devices; medical treatments; progesterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of study identification and selection.
Figure 2
Figure 2
Summarizing classical medical treatments for Adenomyosis. Legend: NSAID: Non-steroidal anti-inflammatory drug, LNG-IUD: Levonorgestrel-releasing intrauterine device, OCP: Oral contraceptive pill, GnRH: Gonadotropin-releasing hormone.

References

    1. Agostinho L., Cruz R., Osório F., Alves J., Setúbal A., Guerra A. MRI for adenomyosis: A pictorial review. Insights Into Imaging. 2017;8:549–556. doi: 10.1007/s13244-017-0576-z. - DOI - PMC - PubMed
    1. Akira S., Mine K., Kuwabara Y., Takeshita T. Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis. Med. Sci. Monit. 2008;15:CR1–CR4. - PubMed
    1. Andersson J.K., Khan Z., Weaver A.L., Vaughan L.E., Gemzell-Danielsson K., Stewart E.A. Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study. Acta Obstet. Gynecol. Scand. 2019;98:1341–1350. doi: 10.1111/aogs.13632. - DOI - PubMed
    1. Andersson J.K., Mucelli R.P., Epstein E., Stewart E.A., Gemzell-Danielsson K. Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020;254:38–43. doi: 10.1016/j.ejogrb.2020.08.040. - DOI - PubMed
    1. Ascher S.M., Arnold L.L., Patt R.H., Schruefer J.J., Bagley A.S., Semelka R.C., Zeman R.K., Simon J.A. Adenomyosis: Prospective comparison of MR imaging and transvaginal sonography. Radiology. 1994;190:803–806. doi: 10.1148/radiology.190.3.8115630. - DOI - PubMed

LinkOut - more resources